Ocular surface squamous neoplasia: management and outcomes.
Hӧllhumer R, Williams S, Michelow P.
Eye (Lond). 2021 Jun;35(6):1562-1573. doi: 10.1038/s41433-021-01422-3. Epub 2021 Feb 9.
The Management of Ocular Surface Squamous Neoplasia (OSSN).
Yeoh CHY, Lee JJR, Lim BXH, Sundar G, Mehta JS, Chan ASY, Lim DKA, Watson SL, Honavar SG, Manotosh R, Lim CHL.
Int J Mol Sci. 2022 Dec 31;24(1):713. doi: 10.3390/ijms24010713.
Medical treatment for ocular surface squamous neoplasia.
Monroy D, Serrano A, Galor A, Karp CL.
Eye (Lond). 2023 Apr;37(5):885-893. doi: 10.1038/s41433-023-02434-x. Epub 2023 Feb 8.
Tumors of the conjunctiva and cornea.
Shields CL, Shields JA.
Indian J Ophthalmol. 2019 Dec;67(12):1930-1948. doi: 10.4103/ijo.IJO_2040_19.
Ocular Surface Fibroma: A Rare, Benign Tumor of the Conjunctiva.
Weppelmann TA, Margo CE, Espana EM.
Ophthalmology. 2025 Feb;132(2):e31. doi: 10.1016/j.ophtha.2024.02.020. Epub 2024 Mar 23.
Updates in Ocular Surface Tumor Diagnostics.
Nanji AA, Mercado C, Galor A, Dubovy S, Karp CL.
Int Ophthalmol Clin. 2017 Summer;57(3):47-62. doi: 10.1097/IIO.0000000000000174.
Ocular Surface Squamous Neoplasia.
Gurnani B, Kaur K.
2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
[Ocular surface squamous neoplasia].
Tóth G, Sándor GL, Gyenes A, Tóth J, Seitz B, Nagy ZZ, Szentmáry N.
Orv Hetil. 2017 Dec;158(51):2011-2022. doi: 10.1556/650.2017.30939.
Ocular Surface Disorders in Patients with Human Immunodeficiency Virus (HIV) Infection.
Ong Beng Seng M, Meyer D, Gichuhi S, Tong L, Sudharshan S, Biswas J, Testi I, Agrawal R.
Ocul Immunol Inflamm. 2020 Oct 2;28(7):1015-1021. doi: 10.1080/09273948.2020.1757122. Epub 2020 Jun 5.
Ocular surface complications of local anticancer drugs for treatment of ocular tumors.
Moon J, Choi SH, Lee MJ, Jo DH, Park UC, Yoon SO, Woo SJ, Oh JY.
Ocul Surf. 2021 Jan;19:16-30. doi: 10.1016/j.jtos.2020.11.006. Epub 2020 Nov 22.
